169 related articles for article (PubMed ID: 3246214)
1. Effect of erdosteine and its metabolites on tracheobronchial mucus production and transport.
Scuri R; Giannetti P; Paesano A
Drugs Exp Clin Res; 1988; 14(11):693-8. PubMed ID: 3246214
[TBL] [Abstract][Full Text] [Related]
2. Nesosteine: a new mucoregulatory agent.
Scuri R; Mondani P; Frova C; Fantini L
Drugs Exp Clin Res; 1986; 12(8):663-70. PubMed ID: 3757762
[TBL] [Abstract][Full Text] [Related]
3. 2-(2,3-Dihydro-5-acetoxy-4,6,7-tribenzofuranyl)acetic acid (IRFI 016): a new antioxidant mucoactive drug.
Scuri R; Giannetti P; Paesano A
Drugs Exp Clin Res; 1990; 16(12):649-56. PubMed ID: 2130008
[TBL] [Abstract][Full Text] [Related]
4. Erdosteine enhances mucociliary clearance in rats with and without airway inflammation.
Hosoe H; Kaise T; Ohmori K
J Pharmacol Toxicol Methods; 1998 Oct; 40(3):165-71. PubMed ID: 10334633
[TBL] [Abstract][Full Text] [Related]
5. Mucolytic and antitussive effects of erdosteine.
Hosoe H; Kaise T; Ohmori K; Isohama Y; Kai H; Takahama K; Miyata T
J Pharm Pharmacol; 1999 Aug; 51(8):959-66. PubMed ID: 10504037
[TBL] [Abstract][Full Text] [Related]
6. Effects of erdosteine and its metabolites on bacterial adhesiveness.
Braga PC; Dal Sasso M; Sala MT; Gianelle V
Arzneimittelforschung; 1999 Apr; 49(4):344-50. PubMed ID: 10337454
[TBL] [Abstract][Full Text] [Related]
7. A method for studying expectorant action in the mouse by measurement of tracheobronchial phenol red secretion.
Coppi G; Gatti MT
Farmaco; 1989 May; 44(5):541-5. PubMed ID: 2789630
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study.
Crisafulli E; Coletti O; Costi S; Zanasi E; Lorenzi C; Lucic S; Fabbri LM; Bertini M; Clini EM
Clin Ther; 2007 Sep; 29(9):2001-9. PubMed ID: 18035199
[TBL] [Abstract][Full Text] [Related]
9. [Effect of a bronchosecretolytic agent on the tracheobronchial expectoration].
Iravani J
Arzneimittelforschung; 1972 Oct; 22(10):1744-6. PubMed ID: 4677067
[No Abstract] [Full Text] [Related]
10. In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine.
Oktem F; Arslan MK; Ozguner F; Candir O; Yilmaz HR; Ciris M; Uz E
Toxicology; 2005 Nov; 215(3):227-33. PubMed ID: 16112787
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of erdosteine and N-acetylcysteine on apoptosis regulation in endotoxin-induced acute lung injury.
Demiralay R; Gürsan N; Ozbilim G; Erdogan G; Demirci E
J Appl Toxicol; 2006; 26(4):301-8. PubMed ID: 16489578
[TBL] [Abstract][Full Text] [Related]
12. Activity of erdosteine on mucociliary transport in patients affected by chronic bronchitis.
Olivieri D; Del Donno M; Casalini A; D'Ippolito R; Fregnan GB
Respiration; 1991; 58(2):91-4. PubMed ID: 1862257
[TBL] [Abstract][Full Text] [Related]
13. Erdosteine.
Dechant KL; Noble S
Drugs; 1996 Dec; 52(6):875-81; discussion 882. PubMed ID: 8957158
[TBL] [Abstract][Full Text] [Related]
14. The effect of erdosteine on airway defence mechanisms and inflammatory cytokines in the settings of allergic inflammation.
Fraňová S; Kazimierová I; Pappová L; Molitorisová M; Jošková M; Šutovská M
Pulm Pharmacol Ther; 2019 Feb; 54():60-67. PubMed ID: 30502381
[TBL] [Abstract][Full Text] [Related]
15. Erdosteine ameliorates neurological outcome and oxidative stress due to ischemia/reperfusion injury in rabbit spinal cord.
Ege E; Ilhan A; Gurel A; Akyol O; Ozen S
Eur J Vasc Endovasc Surg; 2004 Oct; 28(4):379-86. PubMed ID: 15350559
[TBL] [Abstract][Full Text] [Related]
16. Mucoactive agents for airway mucus hypersecretory diseases.
Rogers DF
Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
[TBL] [Abstract][Full Text] [Related]
17. In vivo sampling and biochemistry of tracheobronchial secretions in the fowl. Influence of sulfurdioxide inhalation.
Bauer E
Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):547-50. PubMed ID: 7323449
[TBL] [Abstract][Full Text] [Related]
18. The SH-metabolite I of erdosteine, a mucolytic drug, enhances the inhibitory effect of salbutamol on the respiratory burst of neutrophils.
Dal Sasso M; Bovio C; Culici M; Fonti E; Braga PC
Drugs Exp Clin Res; 2002; 28(4):147-54. PubMed ID: 12512232
[TBL] [Abstract][Full Text] [Related]
19. The effects of erdosteine, N-acetylcysteine, and vitamin E on nicotine-induced apoptosis of pulmonary cells.
Demiralay R; Gürsan N; Erdem H
Toxicology; 2006 Feb; 219(1-3):197-207. PubMed ID: 16377052
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of erdosteine and vitamins C and E combination on ischemia-reperfusion-induced lung oxidative stress and plasma copper and zinc levels in a rat hind limb model.
Sirmali M; Uz E; Sirmali R; Kilbaş A; Yilmaz HR; Altuntaş I; Naziroğlu M; Delibaş N; Vural H
Biol Trace Elem Res; 2007 Jul; 118(1):43-52. PubMed ID: 17848730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
